スマート医療機器 - 世界市場の考察、競合情勢、市場予測（2030年）

世界のスマート医療機器の市場規模は、2030年までに425億5,817万米ドルに達し、2024年～2030年の予測期間にCAGRで7.22%の成長が見込まれます。スマート医療機器に対する需要の増加は主に、不健康な食事や生活習慣、運動不足によるものであり、これらは喘息、糖尿病、高血圧、心血管障害などの慢性疾患の有病率の上昇につながります。さらに、医療産業内でのスマート医療機器におけるインターネット利用の認識と需要の高まりや、データ管理におけるインターネットの採用は、医師が患者の健康を日常的にモニターし、患者が適切な治療を受けていることを確認するのに役立っており、スマート医療機器の需要の増加につながっています。さらに、患者のリアルタイムのデータに対する認識と需要が高まることで、患者の適切なケアが保証されます。さらに、世界中の在宅治療/診断環境に対する需要の高まりが市場を強化し、2024年～2030年の予測期間にスマート医療機器市場の成長に寄与すると見込まれます。

スマート医療機器の市場力学

スマート医療機器市場は、さまざまな理由から製品需要が伸びています。世界中での、遺伝、加齢、肥満、不健康な生活習慣、食習慣の乱れ、運動不足などのさまざまな要因による糖尿病、高血圧、心血管などの慢性疾患の有病率の増加、慢性疾患にかかりやすい高齢患者の増加、医療産業におけるインターネット利用、クラウドベースシステム、AIに対する認識と需要の高まり、データ管理におけるその採用が、市場を強化すると予測されます。

例えば、世界保健機関（WHO）（2022）によると、2019年、糖尿病は9番目に多い死因であり、糖尿病を直接の原因として推定150万人が死亡しました。糖尿病の有病率と死亡率は、高所得国よりも低中所得国で急速に上昇しています。WHOはまた、糖尿病は失明、腎不全、心臓発作、脳卒中の主因であると結論づけています。さらに、国際糖尿病連合（International Diabetes Federation）のDiabetes Atlas第10版（2022）によると、2023年に、全世界で5億3,700万人の成人（20～79歳）が糖尿病を患う可能性があります。この数は、2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。同じ資料によると、成人の糖尿病患者の4人に3人以上が低中所得国に住んでおり、2022年に670万人が糖尿病で死亡しています。糖尿病の有病率の増加は、スマートインスリンペンによるインスリン投与の需要を増加させます。スマートインスリンペンは、スマートフォンのアプリを通じて、体内のグルコースレベルやインスリンレベル、投与するインスリンの量、投与時間などの情報を提供するスマート医療機器の1つです。この情報は、患者と医師の両方が評価することができます。スマートインスリンペンの需要の向上は、スマート医療機器の需要を増加させます。したがって、スマート医療機器市場全体は予測期間に拡大が見込まれます。

さらに、WHO（2022）によると、2030年までに世界の6人に1人が60歳以上になります。60歳以上の人口に占める割合は、世界全体で2020年の10億人から2030年までに14億人に増加します。2050年までに、世界の60歳以上人口は2倍になります。80歳以上の高齢者の数は2020年～2050年に3倍になり、2050年までに4億2,600万人に達すると予測されています。このように、老年人口が増加していることは、年齢が慢性疾患の主な危険因子の1つであることから、慢性疾患の有病率に影響を与えます。慢性疾患の有病率の増加は、スマート医療機器の需要を増加させ、予測期間におけるスマート医療機器市場を強化します。

さらに、医療機器におけるクラウドベースのシステムに対する認識と需要の高まりが、スマート医療機器の全体的な市場成長を促進します。医療機器はUSBやBluetoothを通じてスマートフォンのアプリに接続されます。情報は患者だけでなく、医師も追跡することができます。さらに、クラウドサービスは患者と医師の連絡を改善するだけでなく、医学研究の範囲を向上させます。医療の適切なサイバーセキュリティは、適切なデータの暗号化とサイバー攻撃からの保護を保証します。このようなクラウドベースのシステムを通じて、医師は患者の健康に関するリアルタイムのデータを追跡することができ、必要に応じて適切な治療の変更につなげることができます。このように、スマート医療機器のさまざまな利点が、市場における機器の需要を増加させ、予測期間における機器の全体的な成長を促進します。

当レポートでは、世界のスマート医療機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 スマート医療機器市場レポートのイントロダクション

第2章 スマート医療機器市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価
• 財務ベンチマーク

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 スマート医療機器市場の主な要因の分析

• スマート医療機器市場の促進要因
  • 喘息、糖尿病、高血圧、心血管疾患などの慢性疾患の有病率の増加
  • 医療産業におけるインターネットの使用と、データ管理におけるその採用に対する意識と需要の高まり
  • 診断と治療に向けたリアルタイムのデータ駆動型アプローチに対する意識の向上
  • 在宅治療/診断環境の需要の高まり
• スマート医療機器市場の抑制要因と課題
  • 低中所得国の人々における適切なインフラと実施可能性の欠如
  • プライバシーの問題
  • 特定の医療機器の技術的複雑性
• スマート医療機器市場の機会
  • 患者ケアを改善するための政府による取り組み
  • 医療機器の技術の進歩

第5章 スマート医療機器市場のポーターのファイブフォース分析

第6章 スマート医療機器市場に対するCOVID-19の影響分析

第7章 スマート医療機器市場のレイアウト

• 製品タイプ別
  • 診断機器、モニタリング機器
  • 治療機器
• 流通チャネル別
  • 病院、小売薬局
  • eコマース
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 スマート医療機器市場：世界の企業シェア分析 - 主要3～5社

第9章 スマート医療機器市場の企業と製品のプロファイル

• Sonova.
• Abbott.
• SAMSUNG ELECTRONICS CO., LTD.
• Medtronic Plc.
• CeQur Simplicity
• DEXCOM, INC.
• ENABLE INJECTIONS
• GARMIN LTD.
• INSULET CORPORATION
• JOHNSON & JOHNSON SERVICES, INC
• NEUROMETRIX, INC.
• OMRON HEALTHCARE, INC.
• F. HOFFMAN-LA ROCHE LTD
• SOTERA WIRELESS, INC.
• VITALCONNECT
• WEST PHARMACEUTICAL SERVICES, INC.
• FitBit
• Qardio, Inc.
• Novo Nordisk A/S
• Emperra GmbH E-Health Technologies

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Smart Medical Devices Market in Global (2021-2030)
• Table 4: Smart Medical Device Market in Global by Product Type (2021-2030)
• Table 5: Smart Medical Device Market in Global by Distribution Channel (2021-2030)
• Table 6: Smart Medical Devices Market in Global by Geography (2021-2030)
• Table 7: Smart Medical Devices Market in North America (2021-2030)
• Table 8: Smart Medical Devices Market in North America by Country (2021-2030)
• Table 9: Smart Medical Devices Market in the US (2021-2030)
• Table 10: Smart Medical Devices Market in Canada (2021-2030)
• Table 11: Smart Medical Devices Market in Mexico (2021-2030)
• Table 12: Smart Medical Devices Market in Europe (2021-2030)
• Table 13: Smart Medical Devices Market in Europe by Country (2021-2030)
• Table 14: Smart Medical Devices Market in France (2021-2030)
• Table 15: Smart Medical Devices Market in Germany (2021-2030)
• Table 16: Smart Medical Devices Market in the United Kingdom (2021-2030)
• Table 17: Smart Medical Devices Market in Italy (2021-2030)
• Table 18: Smart Medical Devices Market in Spain (2021-2030)
• Table 19: Smart Medical Devices Market in Russia (2021-2030)
• Table 20: Smart Medical Devices Market in Rest of Europe (2021-2030)
• Table 21: Smart Medical Devices Market in APAC (2021-2030)
• Table 22: Smart Medical Devices Market in APAC by Country (2021-2030)
• Table 23: Smart Medical Devices Market in China (2021-2030)
• Table 24: Smart Medical Devices Market in Japan (2021-2030)
• Table 25: Smart Medical Devices Market in India (2021-2030)
• Table 26: Smart Medical Devices Market in Australia (2021-2030)
• Table 27: Smart Medical Devices Market in South Korea (2021-2030)
• Table 28: Smart Medical Devices Market in Rest of APAC (2021-2030)
• Table 29: Smart Medical Devices Market in Rest of World (2021-2030)
• Table 30: Smart Medical Devices Market in RoW by Region (2021-2030)
• Table 31: Smart Medical Devices Market in Middle East (2021-2030)
• Table 32: Smart Medical Devices Market in Africa (2021-2030)
• Table 33: Smart Medical Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Smart Medical Devices Market in Global (2021-2030)
• Figure 4: Smart Medical Devices Market in Global by Product Type (2021-2030)
• Figure 5: Smart Medical Devices Market in Global by Distribution Channel (2021-2030)
• Figure 6: Smart Medical Devices Market in Global by Geography (2021-2030)
• Figure 7: Smart Medical Devices Market in North America (2021-2030)
• Figure 8: Smart Medical Devices Market in North America by Country (2021-2030)
• Figure 9: Smart Medical Devices Market in the US (2021-2030)
• Figure 10: Smart Medical Devices Market in Canada (2021-2030)
• Figure 11: Smart Medical Devices Market in Mexico (2021-2030)
• Figure 12: Smart Medical Devices Market in Europe (2021-2030)
• Figure 13: Smart Medical Devices Market in Europe by Country (2021-2030)
• Figure 14: Smart Medical Devices Market in France (2021-2030)
• Figure 15: Smart Medical Devices Market in Germany (2021-2030)
• Figure 16: Smart Medical Devices Market in the United Kingdom (2021-2030)
• Figure 17: Smart Medical Devices Market in Italy (2021-2030)
• Figure 18: Smart Medical Devices Market in Spain (2021-2030)
• Figure 19: Smart Medical Devices Market in Russia (2021-2030)
• Figure 20: Smart Medical Devices Market in Rest of Europe (2021-2030)
• Figure 21: Smart Medical Devices Market in APAC (2021-2030)
• Figure 22: Smart Medical Devices Market in APAC by Country (2021-2030)
• Figure 23: Smart Medical Devices Market in China (2021-2030)
• Figure 24: Smart Medical Devices Market in Japan (2021-2030)
• Figure 25: Smart Medical Devices Market in India (2021-2030)
• Figure 26: Smart Medical Devices Market in Australia (2021-2030)
• Figure 27: Smart Medical Devices Market in South Korea (2021-2030)
• Figure 28: Smart Medical Devices Market in Rest of APAC (2021-2030)
• Figure 29: Smart Medical Devices Market in Rest of World (2021-2030)
• Figure 30: Smart Medical Devices Market in RoW by Region (2021-2030)
• Figure 31: Smart Medical Devices Market in Middle East (2021-2030)
• Figure 32: Smart Medical Devices Market in Africa (2021-2030)
• Figure 33: Smart Medical Devices Market in South America (2021-2030)
• Figure 34: Market Drivers
• Figure 35: Market Barriers
• Figure 36: Marker Opportunities
• Figure 37: PORTER'S Five Force Analysis

Smart Medical Devices Market By Product Type (Diagnostic & Monitoring Devices [Blood Glucose Monitors, Heart Rate Monitors, Pulse Oximeters, Blood Pressure Monitors, Breath Analyzers, And Others] And Therapeutic Devices [Oxygen Concentrators & Ventilators, Insulin Pumps & Pens, Hearing Aids, And Others]), By Distribution Channel (Hospital & Retail Pharmacy, E-Commerce, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increased prevalence of chronic disorders such as diabetes mellitus, hypertension, asthma, cardiovascular disease, & others due to genetic factors, obesity, age, & unhealthy lifestyles, and increasing awareness of real time data driven approach in healthcare industry

Global smart medical devices market is estimated to grow at a CAGR of 7.22% during the forecast period from 2024 to 2030 to reach USD 42,558.17 million by 2030. The increase in demand for smart medical devices is primarily attributed to the unhealthy eating & lifestyle and due to lack of physical activity which leads to rising prevalence of chronic diseases such as, asthma, diabetes, hypertension, cardiovascular disorders, and others. Moreover, the increasing awareness and demand of internet use in smart medical devices in the healthcare industry and adoption of it in data management is helping physicians and doctors to monitor the health of a patient on a daily basis and to ensure that the patients are getting proper care, leading to increase in the demand of smart medical devices. Additionally, increasing awareness and demand of real time data of the patient will ensure proper patient care. Furthermore, the rising demand of home-care therapeutic and diagnostic settings across the world are anticipated to bolster the market, thereby contributing to the growth of the smart medical devices market during the forecast period from 2024-2030.

Smart Medical Devices Market Dynamics:

The smart medical devices market is witnessing a growth in product demand owing to various reasons. The increasing prevalence of chronic disorders worldwide such as diabetes mellitus, hypertension, cardiovascular, and others due to various factors such as, genetic, age, obesity, unhealthy lifestyles, poor eating habits and lack of physical activity, increasing number of geriatric patients prone to chronic ailments, and increasing awareness & demand of internet use, cloud - based system and artificial intelligence in healthcare industry and adoption of it in data management across the world are anticipated to bolster the market.

For instance, according to World Health Organization (WHO) 2022, in the year 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths globally, directly caused by diabetes. Diabetes prevalence and mortality has been rising more rapidly in low- and middle-income countries than in high-income countries. WHO also concluded that diabetes is a major cause of blindness, kidney failure, heart attacks, and stroke. Additionally, according to International Diabetes Federation, Diabetes Atlas 10th edition report 2022, in the year 2023, globally 537 million adults (20-79 years) were living with diabetes. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. As per the same source, over three in four adults with diabetes were living in low- and middle-income countries and also diabetes was responsible for 6.7 million deaths in 2022. The increasing prevalence of diabetes will increase the demand of insulin administration by smart insulin pens. Smart insulin pens is one of the smart medical devices which provides information like glucose level & insulin level in the body, the dose of insulin to be delivered, time of administration, and others through an application in the smartphones. This information can be assessed by the patient and the physician both. The rising demand of smart insulin pens will increase the demand of smart medical devices. Thus, the overall market of smart medical devices will amplify in the forecast period.

Moreover, according to WHO 2022, by 2030, one in six people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030 globally. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million by 2050. Thus, the number of geriatric population is increasing which will in turn affect the prevalence of chronic disorders as age is one of the major risk factor for chronic diseases. The increased prevalence of chronic diseases will increase the demand of smart medical devices, thereby bolstering the market of smart medical devices in the forecast period.

Furthermore, the increasing awareness and demand of cloud-based system in the medical devices will drive the overall market growth of smart medical devices. The devices are connected through USB or bluetooth to the application in the smartphones. The information can be tracked by the patient as well as by the physician also. Moreover, the cloud services improve the reach between patients and physicians, as well as the scope of medical research. Appropriate cybersecurity of medical ensures proper data encryption and protection from cyberattacks. Through these cloud-based system real time data about the patient's health can be tracked by the physicians, leading to proper change in treatment if required. Thus, various advantages of smart medical devices will increase the demand of the device in the market, thereby propelling the overall growth of the device in the forecast period.

Moreover, the product launches in local market, in turn, drive the product demand in the market. For instance, in February 2019, OxyGo LLC, an oxygen kit manufacturing company, announced the launch of OxyGo FIT Connect, a bluetooth-enabled portable oxygen concentrator (POC) that integrates with a wireless connectivity platform for remote monitoring. The platform incorporates the My OxyGo Provider Dashboard and the My OxyGo App, which work together to provide real-time monitoring.

Thus, owing to the increasing prevalence of chronic disorders globally and product launches, there will be a rising demand for smart medical devices, in turn increasing the smart medical devices market growth.

However, lack of suitable infrastructure and operability among people in low- and middle-income countries, privacy and data breaching concerns, and technical complexity with certain medical devices might also hamper the smart medical devices market growth.

The ongoing COVID-19 pandemic has significantly increased the market for smart medical devices as the demand of various devices like pulse oximeters, oxygen concentrators, blood monitoring devices, blood sugar monitoring devices has increased in the pandemic. All these devices were helpful in providing a promising treatment to COVID-19 patients. In the initial stages of lockdown and due to stringent rules, supply and manufacturing of the devices was halted for some time as the resources and the raw materials were not avaliable. But, with return of normalcy and masses being vaccinated, the market again picked up the momentum. On the other hand, with the development of telemedicine and e-commerce, the pandemic has enhanced the demand of smart medical devices due to online sales. Many users preferred home delivery of the products like smart medical devices to avoid exposure to the virus. Thus, creating a positive impact in the market.

Smart Medical Devices Market Segment Analysis:

Smart medical devices Market by Product Type (Diagnostic and Monitoring Devices [Blood Glucose Monitors, Heart Rate Monitors, Pulse Oximeters, Blood Pressure Monitors, Breath Analyzers, and Others] and Therapeutic Devices [Oxygen Concentrators & Ventilators, Insulin Pumps & Pens, Hearing Aids, and Others]), By Distribution Channel (Hospital & Retail Pharmacy, E-Commerce, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the smart medical devices market, the diagnostic and monitoring smart medical devices are estimated to hold a significant share in the smart medical devices market in the year 2023. This can be ascribed to the various application associated with the segment.

For instance, pulse oximeter is one of the diagnostic and monitoring smart medical device, that is used to measure the saturation of oxygen carried in the red blood cells. The pulse oximeter is used to measure the oxygen level in various conditions like chronic obstructive pulmonary disease (COPD), asthma, pneumonia, lung cancer, anemia, heart attack or heart failure, and congenital heart disease, and others. The prevalence of these disease is higher in the forecast period, leading to an increased demand of pulse oximeters, therefore surging the demand of diagnostic and therapeutic smart medical devices in the forecast period and further propelling the overall market growth.

Moreover, the demand of such devices increased due to pandemic. Chronic diseases like diabetes, various cardiovascular and respiratory disease increased the risk of COVID-19 and even declined the recovery rate of the patients from the viral infection. This increased the demand of devices like blood pressure and glucose monitoring devices. Further, the device like pulse oximeters were used to monitor the oxygen saturation level in the COVID-19 patients. Thus, the pandemic increased the demand of smart medical devices, leading to the overall market growth in the year 2023.

Moreover, the demand of various other devices like ECG monitoring devices, drug administration devices like insulin and hormonal patches, insulin pens, and pumps increased in the pandemic thereby leading to an overall market growth of smart medical devices.

Moreover, the product launches, in turn, drive the product demand in the market. For instance, in November 2020, Medtronic announced the launch of InPen. It is a reusable smart insulin pen and integrated with real-time Guardian Connect CGM data. InPen is the first and only FDA-cleared smart insulin pen on the market for people on multiple daily injections (MDI).

Thus, owing to the various applications of diagnostic and monitoring devices, there will be an increase in the demand for diagnostic and monitoring smart medical devices, which in turn will drive the smart medical devices market growth.

North America is expected to dominate the overall Smart Medical Devices Market:

Among all the regions, North America is expected to account for the significant share in the global smart medical devices market. Growing incidence of chronic disorders such as, diabetes, hypertension, high triglyceride level, asthma, chronic obstructive pulmonary disorder (COPD), and others due to high consumption of processed food, lack of physical activity & lifestyle changes, increasing exposure of pollution, and others will increase the demand of smart medical devices. Moreover, the surging awareness of real time data driven approach for diagnostics and treatment will increase the demand for smart medical devices in North America, leading to a rise in the overall smart medical devices market growth.

For instance, as per the data published by Centers for Disease Control and Prevention (CDC) 2022, in the year 2019, more than half a million deaths in the United States had hypertension as a primary or contributing cause. As per the same source, it was estimated that in the year 2019 nearly half of adults in the United States had hypertension. Additionally, as per Pan American Health Organization (PAHO) 2022, cardiovascular disease (CVD) is of the leading cause of death in the Americas and high blood pressure accounts for over 50% of CVD. The rising prevalence of hypertension and CVD in the United States will lead to an increased demand of smart medical devices used in diagnosis and monitoring of the disorders. Thus, the demand of smart medical devices such as, blood pressure monitoring device, heart rate monitoring devices, ECG devices, and others will increase in the market. Therefore, the rising demand of smart medical devices will propel the overall market growth of the device in the forecast period.

Furthermore, air pollution is the cause and aggravating factor of many respiratory diseases like chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. For instance, according to WHO 2022, it was estimated that in the year 2019, asthma affected an estimated 262 million in the United States. The inhaled medication can control asthma symptoms and allow people with asthma to lead a normal, active life. The medications are given by medical devices like infusion pumps and sprays. Oxygen supply to the asthmatic patient can be given with smart medical devices like oxygen concentrators and ventilators. The increasing prevalence of respiratory ailments like asthma will increase the demand of pumps, oxygen concentrators and others for the therapeutic purpose, leading to the rising demand of smart medical devices. Therefore, increasing the overall market growth of smart medical devices in the North America region.

Another factor responsible for increasing the product demand is the adaptation of cloud-based and real- time data system in healthcare industry. These adaptions are improving the healthcare industry by providing real-time information of the patient to the doctor. Smart insulin pens or blood glucose monitoring devices gives the real-time information about the insulin and glucose present in a diabetic patient. After this information the physician can amend the dosage of the insulin. In the same manner, blood pressure and heart rate can be continuously monitored by the doctor through the cloud based system. The advancements helps the physicians or doctor to adjust the treatment according to the patient's condition. Thus, various features of cloud-based data management in the smart medical devices will drive the market of the device positively, further leading to the overall market growth of the smart medical devices in the North America.

Smart Medical Devices Market Key Players:

Some of the key market players operating in the smart medical devices market include Sonova., Abbott., Samsung Electronics Co., Ltd., Medtronic Plc., CeQur Simplicity, DEXCOM, INC., Enable Injections, Garmin LTD., Insulet Corporation, Johnson & Johnson Services, Inc, Neurometrix, INC., Omron Healthcare, INC., F. HOFFMAN-LA ROCHE LTD, Sotera Wireless, INC., Vitalconnect, West Pharmaceutical Services, INC., FitBit, Qardio, Inc., Novo Nordisk A/S, Emperra GmbH E-Health Technologies, among others.

Recent Developmental Activities in the Smart Medical Devices Market:

In April 2022, FitBit Inc., announced that it had received approval from the US Food and Drug Administration for an AFib Detection algorithm that can identify atrial fibrillation (AFib).

In March 2022, Novo Nordisk, multinational pharmaceutical company, announced that two smart connected insulin pens, NovoPen 6 and NovoPen Echo Plus, are now available on prescription for people living with diabetes treated with Novo Nordisk insulin in the UK.

In January 2022, Insulet, is an innovative medical device company dedicated to simplifying life for people with diabetes, announced that its Omnipod 5 insulin pump had gained FDA clearance for the use in diabetic patient. Omnipod 5 is a patch-like device capable of adjusting daily doses to changes in the wearer's blood sugar levels.

In February 2022, Qardio, Inc., an American technology company that specializes in heart health monitoring products, announced that the U.S. Food and Drug Administration (FDA) had granted the company 510k clearance for its QardioCore ambulatory ECG device.

In August 2020, Medtronic had announced the acquisition of Companion Medical, manufacturer of InPen. The InPen is a reusable smart insulin pen that uses Bluetooth technology to send dose information to a mobile app.

Key Takeaways from the Smart Medical Devices Market Report Study

• Market size analysis for current smart medical devices market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the smart medical devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global smart medical devices market.
• Various opportunities available for the other competitor in the smart medical devices market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current smart medical devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for smart medical devices market growth in the coming future?

Target Audience who can be benefited from this Smart Medical Devices Market Report Study

• Smart medical devices products providers
• Research organizations and consulting companies
• Smart medical devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in smart medical devices
• Various End-users who want to know more about the smart medical devices market and latest technological developments in the smart medical devices market.

Frequently Asked Questions for Smart Medical Devices Market:

1. What are smart medical devices?

A smart medical devices, is a category of medical device which are equipped with wireless loT technology. This technology links patients to doctors and transmit critical medical data in real time from hospital beds and private homes. Smart personal medical devices provides clinician's real-time data to ensure patients are getting the highest level of care.

2. What is the market for Global smart medical devices?

Global smart medical devices market is estimated to grow at a CAGR of 7.22% during the forecast period from 2024 to 2030 to reach USD 42,558.17 million by 2030.

3. What are the drivers for the Global smart medical devices market?

The smart medical devices market is witnessing a positive market growth owing to increasing prevalence of chronic diseases such as, asthma, diabetes, hypertension, cardiovascular. Moreover, the increasing awareness and demand of internet use in healthcare industry and adoption of it in real-time data management and increasing importance of real time data driven approach for diagnostics and treatment will also propel the market growth of smart medical devices. Additionally, the rising demand of home-care therapeutic and diagnostic settings across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global smart medical devices market?

Some of the key market players operating in the smart medical devices market include Sonova., Abbott., Samsung Electronics Co., Ltd., Medtronic Plc., CeQur Simplicity, DEXCOM, INC., Enable Injections, Garmin LTD., Insulet Corporation, Johnson & Johnson Services, Inc, Neurometrix, INC., Omron Healthcare, INC., F. HOFFMAN-LA ROCHE LTD, Sotera Wireless, INC., Vitalconnect, West Pharmaceutical Services, INC., FitBit, Qardio, Inc., Novo Nordisk A/S, Emperra GmbH E-Health Technologies and, others.

5. Which region has the highest share in smart medical devices market?

North America is expected to hold the highest share in the revenue in the smart medical devices market during the forecast period. Growing incidence of chronic disorders such as, diabetes, hypertension, high triglyceride level, asthma, and others due to high consumption of processed food, lack of physical activity and lifestyle changes will increase the demand of smart medical devices. Moreover, the surging awareness of real time data driven approach for diagnostics and treatment will increase the demand for smart medical devices in North America, leading to a rise in the overall smart medical devices market growth in this region.

Table of Contents

1.Smart medical devices Market Report Introduction

2.Smart medical devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Smart medical devices Market Key Factors Analysis

• 4.1. Smart medical devices Market Drivers
  • 4.1.1. Increase prevalence of chronic diseases such as, asthma, diabetes, hypertension, cardiovascular
  • 4.1.2. Increasing awareness and demand of internet use in healthcare industry and adoption of it in data management
  • 4.1.3. Increasing awareness of real time data driven approach for diagnostics and treatment
  • 4.1.4. Rising demand of home-care therapeutic and diagnostic settings
• 4.2. Smart medical devices Market Restraints and Challenges
  • 4.2.1. Lack of suitable infrastructure and operability among people in low- and middle-income countries
  • 4.2.2. Privacy concerns
  • 4.2.3. Technical complexity with certain medical devices
• 4.3. Smart medical devices Market Opportunities
  • 4.3.1. Initiatives by Governments to Improve Patient Care
  • 4.3.2. Technological advancements in medical devices

5. Smart medical devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Smart medical devices Market

7. Smart medical devices Market Layout

• 7.1. By Product Type
  • 7.1.1. Diagnostic and Monitoring Devices
    • 7.1.1.1. Blood glucose monitors
    • 7.1.1.2. Heart rate monitors
    • 7.1.1.3. Pulse oximeters
    • 7.1.1.4. Blood pressure monitors
    • 7.1.1.5. Breath analyzers
    • 7.1.1.6. Others
  • 7.1.2. Therapeutic Devices
    • 7.1.2.1. Oxygen concentrators and ventilators
    • 7.1.2.2. Insulin pumps and pens
    • 7.1.2.3. Hearing aids
    • 7.1.2.4. Others
• 7.2. By Distribution Channel
  • 7.2.1. Hospital and Retail Pharmacy
  • 7.2.2. E-commerce
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States
    • 7.3.1.2. Canada
    • 7.3.1.3. Mexico
  • 7.3.2. Europe
    • 7.3.2.1. France
    • 7.3.2.2. Germany
    • 7.3.2.3. United Kingdom
    • 7.3.2.4. Italy
    • 7.3.2.5. Spain
    • 7.3.2.6. Russia
    • 7.3.2.7. Rest of Europe
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China
    • 7.3.3.2. Japan
    • 7.3.3.3. India
    • 7.3.3.4. Australia
    • 7.3.3.5. South Korea
    • 7.3.3.6. Rest of Asia Pacific
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East
    • 7.3.4.2. Africa
    • 7.3.4.3. South America

8. Smart medical devices Market Global Company Share Analysis - Key 3-5 Companies

9. Smart medical devices Market Company and Product Profiles

• 9.1. Sonova.
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Abbott.
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. SAMSUNG ELECTRONICS CO., LTD.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Medtronic Plc.
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. CeQur Simplicity
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. DEXCOM, INC.
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. ENABLE INJECTIONS
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. GARMIN LTD.
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. INSULET CORPORATION
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. JOHNSON & JOHNSON SERVICES, INC
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. NEUROMETRIX, INC.
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. OMRON HEALTHCARE, INC.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. F. HOFFMAN-LA ROCHE LTD
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. SOTERA WIRELESS, INC.
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. VITALCONNECT
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. WEST PHARMACEUTICAL SERVICES, INC.
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. FitBit
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Qardio, Inc.
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. Novo Nordisk A/S
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Emperra GmbH E-Health Technologies
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us